Blood 2009,114(26):5331–5341.PubMedCentralPubMedCrossRef 14. Ding Q, et al.: APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest 2011,121(11):4526–4536.PubMedCentralPubMedCrossRef 15. Fabbri M, et al.: MicroRNA-29 family reverts aberrant methylation in lung cancer
by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007,104(40):15805–15810.PubMedCentralPubMedCrossRef 16. Cobimetinib mouse Cittelly DM, et al.: Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Oncogene 2012,2(20):2555–2564. 17. Gebeshuber CA, Zatloukal K, Martinez J: miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. Embo Reports 2009,10(4):400–405.PubMedCentralPubMedCrossRef
18. Xiong Y, et al.: Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010,51(3):836–845.PubMed 19. Calin GA, et al.: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005,353(17):1793–1801.PubMedCrossRef 20. Mott JL, et al.: mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007,26(42):6133–6140.PubMedCentralPubMedCrossRef 21. Yanaihara N, et al.: INCB024360 cost Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006,9(3):189–198.PubMedCrossRef 22. Martinez I, et al.: miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A 2011,108(2):522–527.PubMedCentralPubMedCrossRef
23. Muniyappa MK, et al.: MiRNA-29a regulates the expression of numerous proteins Florfenicol and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 2009,45(17):3104–3118.PubMedCrossRef 24. Xu H, et al.: MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res 2009,69(15):6275–6281.PubMedCentralPubMedCrossRef 25. Santanam U, et al.: Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 2010,107(27):12210–12215.PubMedCentralPubMedCrossRef 26. Cui Y, et al.: MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 In human gastric cancer. Plos One 2011,6(10):e25872.PubMedCentralPubMedCrossRef 27. Sala A: B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 2005,41(16):2479–2484.PubMedCrossRef 28. Roy PG, Thompson AM: Cyclin D1 and breast cancer. Breast 2006,15(6):718–727.PubMedCrossRef 29. Huuhtanen RL, et al.: Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res 1999,59(12):2885–2890.PubMed 30. Poikonen P, et al.: Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer. Br J Cancer 2005,93(5):515–519.PubMedCentralPubMedCrossRef 31.